Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor.
D000328:Adult; D000498:Allyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008297:Male; D008875:Middle Aged; D059408:Pain Management; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D010648:Phenylacetates / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D012217:Rheumatoid Factor / Q000032:analysis*
D000498:Allyl Compounds; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D010647:Phenyl Ethers; D010648:Phenylacetates; D010919:Placebos; D012217:Rheumatoid Factor; D001241:Aspirin